For the Inventor, By the Inventor

Enter assignee name

London, United Kingdom

Immodulon Therapeutics Limited

USPTO Granted Patents = 12

CIPO Patents = 10

EPO Patents = 6

Trademarks = 2

Forward Citations = 29

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Charles Akle (11 out of 11 patents)

John Grange (10 out of 10 patents)

Kevin Bilyard (6 out of 6 patents)

4. Satvinder Mudan (3 out of 3 patents)

5. Laura Rosa Brunet (2 out of 2 patents)

6. Christopher A Lowry (1 out of 4 patents)

7. Thorsten Hagemann (1 patent)

8. John Lawson Stanford (16 patents)

9. Graham Mcintyre (0 patent)

12 patents: Sort by Forward Citations

1. 12042532 - Checkpoint inhibitor and a whole cellfor use in cancer therapy (2024-07-23),

2. 11554166 - Immunogenic treatment of cancer (2023-01-17),

3. 11318193 - Immunogenic treatment of cancer (2022-05-03),

4. 11207405 - Checkpoint inhibitor and a whole cellfor use in cancer therapy (2021-12-28),

5. 11000584 - Checkpoint inhibitor and a whole cellfor use in cancer therapy (2021-05-11),

6. 10994002 - Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy (2021-05-04),

7. 10925952 - Checkpoint inhibitor and a whole cellfor use in cancer therapy (2021-02-23),

8. 10736864 - Immunotherapeutic agent (2020-08-11),

9. 10610578 - Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy (2020-04-07),

10. 10610577 - Checkpoint inhibitor and a whole cellfor use in cancer therapy (2020-04-07),

11. 10071124 - [object Object] (2018-09-11),

12. 8617520 - Cancer therapy (2013-12-31),

Immodulon Therapeutics Limited is a biopharmaceutical company specializing in cancer immunotherapies. With a focus on developing novel immunotherapeutics that boost the body's natural defense mechanisms against cancer, Immodulon aims to revolutionize cancer treatment. The company's cutting-edge research and development efforts have led to the creation of innovative immunotherapeutic products that have shown promising results in clinical trials. Immodulon is committed to improving the lives of cancer patients worldwide by advancing the field of cancer immunotherapy.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

12 Patents

#245 in London

#1,433 in United Kingdom

#46,692 in the World

London, United Kingdom

Immodulon Therapeutics Limited

Forward Citations = 29

11 inventors:

Charles Akle (11 out of 11 patents)

John Grange (10 out of 10 patents)

Kevin Bilyard (6 out of 6 patents)

4. Satvinder Mudan (3 out of 3 patents)

5. Laura Rosa Brunet (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…